10 funding opportunities found in this category. Change the order of results: Newest First Oldest First Expiring Soonest Expiring Latest Lowest Award to Highest Highest Award to Lowest
Targeted Research Initiative for Severe Symptomatic Epilepsies
Application Deadline: March 21, 2012
Award Amount: up to $50,000 maximum for one year
Apply via Proposal Central website
The Epilepsy Foundation is pleased to announce its first annual Targeted Research Initiative for Severe Symptomatic Epilepsies grant program. This program seeks to better understand, diagnose, identify co morbidities, and treat these rare but devastating epilepsy syndromes. The catastrophic epilepsies of childhood commonly include Othara's syndrome, severe myoclonic epilepsy in infancy (Dravet), infantile spasm, progressive myoclonic epilepsies, Lennox-Gastaut syndrome, Doose syndrome, Sturge-Weber syndrome, Rasmussen encephalitis and, in later childhood, Landau-Kleffner syndrome (LKS) and continuous spike and wave in slow-wave sleep (CSWSS).
Applicants may request up to $50,000 maximum for one year.
Epilepsy Foundation 8301 Professional Place Landover, MD 20785-7223 Telephone: 1-800-332-1000 Fax: 1-301-577-2684 Email: ContactUs@efa.org
Barth Syndrome 6th International Scientific, Medical & Family Conference Scholarship Program
June 25th through June 30th, 2012 St. Pete Beach, Florida
New for 2012, the Barth Syndrome Foundation has a limited number of travel scholarships (up to US $800 each) for qualifying physicians, clinical residents/fellows/students, nurses, and other allied health professionals to help defray the cost of attending the BSF´s 2012 International Conference. This new program is designed to encourage medical practitioners to increase their knowledge about and improve their care of Barth syndrome individuals.
Conference Scholarship Application forms must be submitted to Matthew J. Toth, PhD at matthew.toth@barthsyndrome.org by April 15, 2012. Please allow several days before the deadline to resolve questions or problems. NO extensions will be granted. Scholarship awardees will be notified of the final selection decisions by e-mail on or before April 22, 2012.
Barth Syndrome 6th International Scientific, Medical & Family Conference Poster Session and Poster Travel Stipends
As in previous years, a poster session is planned for BSF's 2012 International Conference. The poster session is an important part of the Conference, and the poster presenters are encouraged to apply for a stipend (up to US $800) to help defray the cost of their attendance.
Abstracts with completed application forms must be submitted to Matthew J. Toth, PhD at matthew.toth@barthsyndrome.org by April 15, 2012. Please allow several days before the deadline to resolve questions or problems. NO extensions will be granted. Presenting authors will be notified of the final selection decisions by e-mail on or before April 22, 2012.
Lymphatic Malformation Research Opportunity
Liam’s Land Organization awards grants to applicants who seek to conduct research to find the cause, treatment, or cure for lymphatic malformation (also known in the past as cystic hygroma or lymphangioma).
Grant application deadline is February 5, 2012, for consideration at the April 2012 Board of Director’s meeting.
Application Guidelines
The following general guidelines apply to our research grants:
a. Principal investigators (PI) must hold post-doctoral position or beyond. b. Proposed projects must have specific relevance to lymphatic malformations and show promise for contributing to the scientific advancements, disease treatments, or cures in the field of study. c. Awards will be granted only to applicants affiliated with institutions with 501(c)(3) statuses or equivalent for foreign institutions.
Funding Guidelines and Limitations The following are general guidelines and limitations for our research grants: a. Projects will ordinarily be funded for a two year period. Under exceptional circumstances, funding will be continued for a third and fourth year of the project. b. Grant awards will be provided in amounts up to $25,000 annually. c. Payments will be made on a quarterly basis at the beginning of each quarter, with exception of the final quarter of each year of the grant, which will be paid thirty days after receipt and approval of the year-end report as specified in Section VI below. d. LLO reserves the right to withhold payment at any time pending resolution of any discrepancies in the use of funds, and/or if the specific aims are not met, all as set forth in the grant proposal and any revisions required. e. Awards may not be contributed to a unified or pooled fund that will be used to award grants or support other projects. f. Grants are awarded on the basis of the content of the proposal, as well as the specified Principal Investigator (PI) and sponsoring institution. If the PI terminates his/her affiliation with the institution identified in the grant award, and wishes to continue the project at another institution, the PI must notify LLO in writing and obtain approval. LLO reserves the right to require resubmission of the grant with the appropriate changes in staff and/or venue, and LLO reserves the right to such a change. g. If the PI wishes to discontinue the project prior to completion, he/she must notify LLO in writing within sixty days of the termination of work on the project. The original institution identified in the grant award shall have the opportunity to identify another PI within sixty days of notification. LLO reserves the right to require resubmission of the grant with the appropriate changes in staff and LLO reserves the right to reject a change. If the original institution does not wish to continue the project, the remaining funds must be returned to LLO. h. The following will not be funded: i. Overhead or indirect cost ii. Collaborator salaries iii. General institutional expenses iv. Journal subscriptions, advertisements, tuition fees, professional society dues, meals, receptions, seminars, or parking fees. v. Any research that does not fall within LLO areas of interest
2012 Pfizer Fellowships in Amyloidosis
This fellowship represents an opportunity for young investigators to spend 2 years of their career adding to the science of the amyloidoses. Applications for this fellowship are welcome from programs and institutions that focus on educating clinicians on the recognition, diagnosis and treatment of patients with amyloidosis, especially those of the hereditary/familial type.
Funds Available: One award of up to $100,000, paid over 2 years at $50,000 per year
Application Deadline: February 10, 2012
Awards Announced: April 1, 2012
Funding Begins: July 2012
Eligibility
Institutions
Must be an accredited US-based academic institution Must not be located in the State of Vermont The institution cannot host another recipient of this same award during the proposed term Senior staff, division heads or department chairs should work on behalf of their institution to prepare and submit an application for consideration
Proposal
Proposals requesting to study any pharmaceutical product are ineligible for MAP awards. Requests to study Pfizer products must to be submitted through our Investigator Initiated Research portal (http://www.pfizer.com/research/investigator/investigator_initiated_research.jsp). Basic science and/or fundamental research (animal model, in-vivo / in-vitro) are not permissible Proof of harm or otherwise highly invasive studies (unethical) will not be considered
Fellows
Prospective fellows at the institution CANNOT apply directly for the award. A Fellow may assist the senior staff, division head or department chair at the institution in the development of the grant application A fellow supported by a Pfizer MAP fellowship must have the opportunity to carry out supervised biomedical or clinical research with the primary objective of preparing them for their respective discipline and subspecialty Upon receipt of the grant award, the Fellow selected by the Institution must meet the following criteria: US citizen or foreign national with permanent US residence Hold an advanced degree (i.e., MD, DO, NP, PharmD, etc.) Be enrolled in fellowship program (Clinical award recipients) Hold a non-tenured, junior faculty appointment (Research award recipients)
Selection Process
Quality of the Research Proposal:
Is the proposal innovative, significant, and feasible, and does it have depth? Does the proposal reference interdisciplinary knowledge? Does the proposal bridge the academic and practice communities?
Quality of the Institution:
Assessment of the academic and/or medical facilities and the institution's commitment to research. Are the institutional support, equipment and other physical resources available to the fellow(s) adequate for the proposed project? Will the project benefit from the unique features of the environment, subject populations, or collaborative arrangements offered by the institution?
Quality of the Mentor(s):
Is the mentor(s) well suited to the project? What is the mentor(s) experience within the field? Is the mentoring relationship beneficial for the development of potential fellow?
Contact Us
Questions about the programs and/or applications:
The Pfizer MAP Team Phone: (877) 254-6953 E-mail: MAPinfo@clinicalconnexion.com
Cystic Fibrosis Foundation Summer Scholarships in Epidemiology
Application Deadline: April 1
Awards are available to increase skills in epidemiology for M.D.s currently working in cystic fibrosis. Scholarships cover tuition and expenses up to $2,000 for selected summer epidemiology programs. Course work should include biostatistics and epidemiology, particularly clinical epidemiology and/or clinical trials.
For More Information
Individuals interested in any of the above-mentioned funding program may contact the Grants and Contracts Office for further information and/or to discuss the potential relevance of their studies or research to the mission of the CF Foundation and to the objectives of these programs. Please direct inquiries to:
Grants and Contracts Office Cystic Fibrosis Foundation 6931 Arlington Road Bethesda, MD 20814 (800) FIGHT CF (301) 951-4422 grants@cff.org
Dr. Gunnar B. Stickler Scholarship
The Stickler Involved People’s support group is proud to offer the Dr. Gunnar B. Stickler Scholarship Program. Dr. Stickler researched and discovered common genetic deficiencies in children and adults in the early 1960’s now known as Stickler Syndrome. His discoveries are proving important to today’s genome research. He desires to assist deserving college-bound adults afflicted with Stickler Syndrome to pursue their dreams and education goals. His understanding of the financial burdens for medical treatment (often required in raising a Stickler Syndrome child) and the need for higher education to help assure success as an adult, demonstrates his compassion for these children. The award is a Scholarship in the amount of $500 per year up to a maximum of 4 years.
Eligibility: The scholarship application will be available to graduating students of any American high school who plan to apply for admission to any accredited public or private community, junior, or four-year college or university or vocational-technical school. Applicants must have a minimum grade point average (GPA) of 3.0 on a 4.0 scale or equivalent. You must be diagnosed with Stickler Syndrome by a primary care physician or Geneticist (on their letterhead), which must be attached to your application.
Award: One new Scholarship will be awarded each year. The award is $500 per year until the Recipient graduated not to exceed 4 years. The Recipient must maintain a 3.0 or better GPA to continue to receive the annual award. Failure to meet this requirement for any semester will suspend your award until two consecutive semester’s GPA is 3.0 or better. Your college transcripts are due by July 1st to receive your next award installment. Scholarships are awarded on the basis of merit and financial need.
Application: Interested students must fill out the application form completely and have all parties sign it. They must provide a Physician’s letter diagnosing their Stickler Syndrome. Students must enclose their high school transcripts (sealed). Applications are due by June 15th and will be reviewed by the Stickler Involved People’s selection committee by July 15th annually. The scholarship winner will be notified by mail by August 1st each year. Applicant’s final High School semester grades must be included with their transcripts.
Mail application to:
Stickler Involved People c/o Pat Houchin Gunnar B. Stickler Scholarship Award 15 Angelina Augusta, KS 67010
Shwachman Diamond Syndrome Foundation Research Grants
Shwachman-Diamond Syndrome (SDS) is a multi-system autosomal-recessive disorder characterized by exocrine pancreatic dysfunction, and varying degrees of marrow dysfunction with cytopenias. Many associated clinical problems have also been described, including skeletal anomalies, metaphyseal dysostosis, rib abnormalities, cleft palate, dental abnormalities and others. Shwachman-Diamond Syndrome Foundation (SDSF) is a nonprofit support organization actively helping the victims of this disease. SDSF is accepting grant requests for research relevant to this disease. Any high quality, innovative research proposal deemed relevant to SDS will be considered.
The following are areas of particular interest: Investigate or evaluate potential novel therapies or potential novel therapeutic strategies- preferred applications Evaluate predictors of bone marrow abnormalities to determine their correlation with the disease Determine the causes of bone marrow failure and leukemia Further delineate the pathogenesis of pancreatic disease Investigations related to adult patient presentation, management, and care including transition from pediatric-centered to adult care Eligibility Persons applying for these grants must be in a faculty position with authority to hold an independent research grant (not a training position). Letter of Intent The potential applicant should write a one-page letter of intent to the SDSF, indicating the applicant’s position and affiliation, describing their planned project, and explaining its relevance to Shwachman-Diamond Syndrome. These letters are reviewed by SDSF’s Medical and Scientific Advisory Board (MSAB) grant review process. Purpose This letter will be used to identify applicants who will be asked to provide a full application. Dates The letter is due no later than March 12th. All those who have submitted a letter of intent will receive a reply by April 5th. All Grant Applications must be submitted by May 15th. The final grant decision will be announced by July 31st with a November 1st start date. Terms of Support Support may be provided for up to two (2) years in an amount not to exceed $65,000 per year, including expenses. The second year funding will not be released until a Progress Report has been reviewed and approved by the MSAB. The date for the Progress Report is October 1st. Applicants may submit only one grant application at a time, and may hold only one grant at a time. If you would like us to send you a grant application, have any questions regarding the grant process or have an interest in the disease, please contact SDSF. Please call toll free 1-888-825-SDSF (7373) or via email at info@shwachman-diamond.org.
Shwachman-Diamond Syndrome Foundation 127 Western Avenue Sherborn, MA 01770
Call for Applications: National Spasmodic Dysphonia Association Research Grant Program
The National Spasmodic Dysphonia Association is seeking research applications for new investigator startup grants or post doctoral study focused on research aimed at increasing understanding of spasmodic dysphonia.
Small seed money grants to new or established investigators for up to $20,000 (excluding indirect costs) per year will be awarded. These can be for startup grants enabling successful applicants to subsequently seek funding from the National Institutes of Health or may provide partial support for post doctoral research training relating to spasmodic dysphonia.
We are interested in hypothesis-driven research related to new approaches aimed at increasing understanding of Spasmodic Dysphonia that focuses on the following areas:
Endogenous and environmental risk factors for the development of Spasmodic Dysphonia Pathophysiology of central nervous system dysfunction in Spasmodic Dysphonia Animal models for Spasmodic Dysphonia Novel approaches to the treatment of Spasmodic Dysphonia Diagnostic tools for Spasmodic Dysphonia Controlled studies of treatment outcomes in Spasmodic Dysphonia
The deadline to submit an application is March 1 each year.
National Spasmodic Dysphonia Association 300 Park Boulevard Suite 415 Itasca, IL 60143 Phone: 800-795-6732 Fax: 630-250-4505 NSDA@dysphonia.org
Cystinosis Foundation Deanna Lynn Potts Scholarship
Deanna Lynn Potts was born with Cystinosis and lived to be 27 years old. Before she died, she discussed her wishes to start a scholarship fund for children with Cystinosis.
We know how devastating a chronic illness can have on a family emotionally, physically, socially, and financially. Children with Cystinosis are living longer, thanks to medical science and therefore, embarking on careers.
These careers require education. Education is expensive, yet something we do not want to deprive our children of in our world today. Due to the financially draining medical costs, it might prove difficult to send a child to college.
Through this fund, we hope to help some of those students.
PURPOSE: To provide supplemental financial assistance to an undergraduate student diagnosed with Cystinosis enrolled in an accredited collegiate or vocational program.
SCHOLARSHIP AWARD: A $1000 scholarship awarded annually. The award is contingent upon the winners acceptance to an accredited college, university, or vocational program and will be payable to the education institution to be applied to tuition, room and board.
ELIGIBILITY: Each candidate must be a current high school senior, who has Cystinosis and have a financial need.
APPLICATION PROCEDURE:
Documentation/verification of Cystinosis (e.g. letter from physician.) An official copy of high school transcript. Two letters of recommendation from current teachers/faculty members and/or counselors regarding applicant's scholastic aptitude and personal qualifications. An essay of 500 words. We want to know a person who has played a vital role in student's life. How? Why? The essay should be typewritten and double spaced A copy of the previous year's income tax return.
JUDGING CRITERIA: The essay will earn a possible 40 points and will be judged on the basis of rationale, grammar and comprehension. Transcripts and letters of recommendation will carry a possible additional 20 points. The Cystinosis Foundation Board will establish an independent judging panel to evaluate and rate the applicants. The decision of the judges is final. Finalists may be interviewed before selection is made.
DEADLINE FOR APPLICATION: Application and all accompanying documents must be received at the Cystinosis Foundation Office in a single, flat package by March 30th of each year. You can call the Cystinosis Foundation for an application 888-631-1588. Print the Application and mail it to the Cystinosis Foundation.
Remember, the deadline for receiving applications is March 30th of each year.
1
